v3.23.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2022   230,706        
Beginning balance at Jan. 31, 2022 $ 1,037,643 $ 115 $ 1,991,807 $ (964,918) $ (1,240) $ 11,879
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   633        
Issuance of common stock upon exercise of options 4,919 $ 1 4,918      
Issuance of common stock under RSU and PSU release (in shares)   1,738        
Issuance of common stock under employee stock purchase plan (in shares)   263        
Issuance of common stock under employee stock purchase plan 34,445   34,445      
Vesting of early exercised stock options 1,470   1,470      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   28        
Issuance of common stock for founders holdbacks related to acquisitions 5,126   5,126      
Stock-based compensation expense 230,559   230,559      
Capitalized stock-based compensation 8,379   8,379      
Net income (78,722)     (80,808)   2,086
Non-controlling interest 3,963         3,963
Other comprehensive income (loss) (4,435)       (4,435)  
Ending balance (in shares) at Jul. 31, 2022   233,368        
Ending balance at Jul. 31, 2022 1,243,347 $ 116 2,276,704 (1,045,726) (5,675) 17,928
Beginning balance (in shares) at Apr. 30, 2022   232,018        
Beginning balance at Apr. 30, 2022 1,116,997 $ 116 2,103,054 (996,441) (4,188) 14,456
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   226        
Issuance of common stock upon exercise of options 1,814   1,814      
Issuance of common stock under RSU and PSU release (in shares)   852        
Issuance of common stock under employee stock purchase plan (in shares)   263        
Issuance of common stock under employee stock purchase plan 34,445   34,445      
Vesting of early exercised stock options 735   735      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   9        
Issuance of common stock for founders holdbacks related to acquisitions 1,422   1,422      
Stock-based compensation expense 129,783   129,783      
Capitalized stock-based compensation 5,451   5,451      
Net income (48,313)     (49,285)   972
Non-controlling interest 2,500         2,500
Other comprehensive income (loss) (1,487)       (1,487)  
Ending balance (in shares) at Jul. 31, 2022   233,368        
Ending balance at Jul. 31, 2022 1,243,347 $ 116 2,276,704 (1,045,726) (5,675) 17,928
Beginning balance (in shares) at Jan. 31, 2023   235,777        
Beginning balance at Jan. 31, 2023 $ 1,487,434 $ 118 2,612,705 (1,148,163) (1,019) 23,793
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares) 585 585        
Issuance of common stock upon exercise of options $ 4,125   4,125      
Issuance of common stock under RSU and PSU release (in shares)   1,944        
Issuance of common stock under employee stock purchase plan (in shares)   450        
Issuance of common stock under employee stock purchase plan 45,432 $ 1 45,431      
Vesting of early exercised stock options 0          
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   18        
Issuance of common stock for founders holdbacks related to acquisitions 2,538   2,538      
Issuance of common stock for board of directors (in shares)   1        
Issuance of common stock for board of directors 167   167      
Stock-based compensation expense 292,941   292,941      
Capitalized stock-based compensation 18,468   18,468      
Net income 8,975     8,963   12
Non-controlling interest 8,088         8,088
Other comprehensive income (loss) 1,932       1,932  
Ending balance (in shares) at Jul. 31, 2023   238,775        
Ending balance at Jul. 31, 2023 1,870,100 $ 119 2,976,375 (1,139,200) 913 31,893
Beginning balance (in shares) at Apr. 30, 2023   237,099        
Beginning balance at Apr. 30, 2023 1,634,359 $ 118 2,752,716 (1,147,672) 139 29,058
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of options (in shares)   210        
Issuance of common stock upon exercise of options 1,474   1,474      
Issuance of common stock under RSU and PSU release (in shares)   1,011        
Issuance of common stock under employee stock purchase plan (in shares)   450        
Issuance of common stock under employee stock purchase plan 45,432 $ 1 45,431      
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   5        
Issuance of common stock for founders holdbacks related to acquisitions 889   889      
Issuance of common stock for board of directors 88   88      
Stock-based compensation expense 163,811   163,811      
Capitalized stock-based compensation 11,966   11,966      
Net income 8,476     8,472   4
Non-controlling interest 2,831         2,831
Other comprehensive income (loss) 774       774  
Ending balance (in shares) at Jul. 31, 2023   238,775        
Ending balance at Jul. 31, 2023 $ 1,870,100 $ 119 $ 2,976,375 $ (1,139,200) $ 913 $ 31,893